All Viruses articles – Page 38
-
NewsNanoparticles designed to trap and neutralise large amounts of SARS-CoV2
Researchers have developed a new class of nanostructures capable of trapping and neutralising large quantities of the SARS-CoV2 virus particles, both in liquid solutions and on the surface of materials.
-
NewsWashington coast avian flu outbreak devastated Caspian terns, jumped to seals
An epidemiological study found that 56% of a large breeding colony of Caspian terns died from a 2023 outbreak of highly pathogenic avian influenza at Rat Island in Washington state. Since then, no birds have successfully bred on the island.
-
NewsPathogens that cling to microplastics may survive wastewater treatment
Wastewater treatment fails to kill several human pathogens when they hide out on microplastics in the water, reports a new study.
-
NewsNasal swab tests predict COVID-19 disease severity
New reserach is providing a more precise prediction of COVID-19 severity that can be found by looking at autoantibodies in the nasal cavity, leading to more personalized treatment plans.
-
NewsBacteria breakthrough could accelerate mosquito control schemes
Mosquito larvae grow faster if they’re exposed to particular bacteria, according to a new study that could help global health programmes.
-
NewsNew findings on animal viruses with potential to infect humans
Scientists investigating animal viruses with potential to infect humans have identified a critical protein that could enable spillover of a family of organisms called arteriviruses.
-
NewsRSV vaccines effective, but more people need to get them
Since their introduction last year, researchers have been monitoring the real-world impact of the new respiratory syncytial virus (RSV) vaccines.
-
NewsTrial of rectal microbicide for HIV prevention begins in US
A clinical trial has launched to examine the safety and acceptability of a novel rectal HIV microbicide douche containing the antiretroviral drug tenofovir.
-
NewsSilent intruder: How the cold sore virus maps its way through the brain
Researchers provide a better understanding of the long-term consequences of HSV-1 infection.
-
NewsTrick and Treat: Black cat’s prey harbored a new virus
First find in the U.S. of jeilongvirus, which can rarely cause serious illness.
-
FeaturesEvolution of the Infectious pancreatic necrosis virus and its potential reemergence
Infectious pancreatic necrosis (IPN) virus has long been a persistent threat to aquaculture, particularly the salmonid industry. Could the evolutionary fitness of IPNV, governed by quasi-species theory and high mutation rates, lead to a new outbreak.
-
NewsBovine H5N1 influenza from infected worker transmissible and lethal in animal models
A highly pathogenic avian influenza H5N1 virus, isolated from the eye of a farm worker who became infected through contact with dairy cows, was lethal in mice and ferrets infected in a high-containment laboratory environment.
-
NewsExperts develop laboratory toolkit for patients with viral hemorrhagic fevers such as Marburg virus disease
New resource provides guidance for healthcare facilities to perform basic laboratory testing in a safe and effective manner for patients at risk for Viral Hemorrhagic Fevers.
-
NewsVaccinating children for mpox would significantly reduce deaths in the DRC
Vaccinating children under five-years-old in endemic mpox regions in the Democratic Republic of the Congo (DRC) would significantly reduce the number of deaths in the country, according to a new analysis.
-
NewsPolar bears’ exposure to pathogens is increasing as their environment changes
As the Arctic warms, polar bears now face a greater risk of contracting several pathogens than bears three decades ago, a new study reveals.
-
NewsNovel antibody platform tackles viral mutations
Scientists have developed an innovative antibody platform aimed at tackling one of the greatest challenges in treating rapidly evolving viruses like SARS-CoV-2: their ability to mutate and evade existing vaccines and therapies.
-
NewsMERS coronavirus vaccine tested as safe and effective in phase Ib clinical trial
The safety, immunogenicity and optimal dosing regimen of the MVA-MERS-S vaccine candidate have been investigated in a phase Ib study in healthy individuals who were previously infected with SARS-CoV-2.
-
NewsMajor antimicrobial power boost as phages form into surprising flower shapes
Researchers treated bacteria-eating viruses so they could be viewed alive under an electron microscope and coaxed them to join together into flower-like shapes - discovering that this made them 100 times more efficient.
-
NewsStudy uncovers how Covid-19 is so good at defeating the innate immune response
The novel coronavirus SARS-CoV-2 has an enzyme that can counteract a cell’s innate defense mechanism against viruses, explaining why it is more infectious than the previous SARS and MERS-causing viruses.
-
NewsAncient viral DNA in human genome linked to multiple sclerosis and amyotrophic lateral sclerosis
New research has revealed a connection between ancient viral DNA embedded in the human genome and the genetic risk for two major diseases that affect the central nervous system.